Skip to content
Specimen Atlas of Research Peptides30 plates · MIT
Side-by-side · Research reference

Melanotan-IIvsSemax

Side-by-side comparison across mechanism, dosage, evidence, side effects, administration, and stack synergies. Citations on every claim where available.

APhase 1Reviewed9/43 cited
BHuman-MechanisticDraft12/39 cited
Melanotan-II
MC1R + MC4R agonist · Tanning + sexual response
0.25–1.0 mgPer doseDorr 1996
Phase 1Evidence levelDorr 1996
~1 hrHalf-life
SQ · Abdomen · Loading 5–7 days, then maintenance
Semax
Cognitive enhancer · Russian Pharma
200–600 mcg/doseIntranasalKaplan 2017
HumanMechanisticKaplan 2017
~30 minOnset
Intranasal · 2–3×/day during cognitive demand

01Mechanism of Action

Parameter
Melanotan-II
Semax
Primary target
MC1R (skin) + MC3R + MC4R (CNS sexual / appetite)Dorr 1996
BDNF / NGF expression + monoamine modulationKaplan 2017
Pathway
MC1R agonism → melanocyte tyrosinase → eumelanin synthesis. MC4R → autonomic sexual arousal centresDorr 1996Simerly 2023
↑ BDNF + NGF synthesis + 5-HT modulation → neuroplasticity + anxiolysis + cognitive enhancementKaplan 2017
Downstream effect
Skin darkening, photo-protection, increased sexual desire / spontaneous erectionDorr 1996
Improved memory + attention; reduced anxiety; neuroprotection in ischemiaKaplan 2017
Feedback intact?
Origin
Cyclic 7-AA modified α-MSH analog; designed at University of ArizonaDorr 1996
Synthetic 7-AA peptide derived from ACTH(4-7) with C-terminal Pro-Gly-Pro stabilising tailKaplan 2017
Antibody development

02Dosage Protocols

Parameter
Melanotan-II
Semax
Loading phase
0.25–0.5 mg/day SQ × 5–7 daysDorr 1996
Builds up to visible tan.
Maintenance
0.5–1.0 mg 1–2×/week
After visible tan develops; supports with UV exposure.
Frequency
Daily during loading; 1–2× per week maintenance
2–3× per day during cognitive demand
Lower / starter dose
0.1 mg / day
Conservative starter — assess tolerability for nausea.
100 mcg / dose
Evidence basis
Phase 1 + anecdotalDorr 1996
Human-mechanistic + Russian clinicalKaplan 2017
Duration
8–12 weeks per cycle
10–14 day cycles, repeated PRN
Reconstitution
Bacteriostatic water; protect from light
Pre-formulated nasal spray (commercial); research vial: bacteriostatic water
Timing
Evening preferred (24h tan-development cycle)
Morning + early afternoon
Half-life
~1 hour plasma; effects on melanocytes persist days
Short plasma; CNS effect lasts ~3–6 hr
Standard dose
200–600 mcg / dose intranasalKaplan 2017

04Side Effects & Safety

Parameter
Melanotan-II
Semax
Nausea
Common, especially loading phase
Flushing
Common transient
Spontaneous erection
Common in men — MC4R cross-effectDorr 1996
Increased mole / freckle pigmentation
Existing moles darken; new lesions possible
Melanoma risk
Theoretical concern — increased melanocyte activity; CAUTION in melanoma history
Appetite suppression
MC4R-mediated; mild
Pregnancy / OB
Contraindicated
Avoid
Nasal irritation
Mild burning or congestion (transient)
Sleep disruption
Late-day dosing may interfere with sleep
Headache
Uncommon, transient
Long-term safety
Limited Western RCT data
Absolute Contraindications
Melanotan-II
  • ·History of melanoma or atypical mole syndrome
  • ·Pregnancy / breastfeeding
  • ·Active uncontrolled hypertension
Semax
  • ·Pregnancy / breastfeeding
Relative Contraindications
Melanotan-II
  • ·Significant freckling / dysplastic nevus
  • ·Personal or family melanoma history
Semax
  • ·Active psychiatric instability
  • ·Concurrent strong stimulants

05Administration Protocol

Parameter
Melanotan-II
Semax
1. Reconstitution
Add 2 mL bacteriostatic water to 10 mg vial → 5 mg/mL = 500 mcg per 0.1 mL. Light-protected.
Pre-formulated nasal spray (commercial) or research vial reconstituted with bacteriostatic water.
2. Injection site
SQ — abdomen. Rotate sites.
Intranasal — 2–3 sprays per nostril per dose. Tilt head slightly back.
3. Timing
Evening preferred. UV exposure (sunlight or tanning bed) helps develop tan.
Morning + early afternoon. Avoid evening (sleep disruption).
4. Storage
Lyophilised: refrigerate, light-protected. Reconstituted: refrigerate ≤30 days.
Refrigerate after reconstitution; light-protected.
5. Needle
29–31G insulin syringe.
Cycle on/off to avoid neurochemical adaptation.

06Stack Synergy

Melanotan-II
— no documented stacks
Semax
+ Selank
Moderate
View Selank

Semax (cognitive enhancer, BDNF/NGF) and Selank (anxiolytic + immune) form the canonical Russian "neuro stack" — both intranasal peptide bioregulators with complementary axes. Semax for cognitive demand; Selank for stress mitigation.

Semax
200–600 mcg intranasal · morning + afternoon
Selank
150–300 mcg intranasal · midday + early evening
Primary benefit
Cognitive enhancement + stress mitigation